To: President Donald Trump
Chronic pain sufferers have no voice. This is a human rights violation. Please listen president T...
We want President Trump to receive this petition and take it seriously. There are thousands of chronic pain sufferers being hugely undertreated due to the CDC guidelines. We have never been given a voice and have been severely dismissed. As we are the citizens who actually need these medications; we feel our stories, worries, ideas and advice matter heavily.
Why is this important?
Let's keep this going. Really share it up on Facebook and twitter. I will be sending this to the president with some other info. If nothing else he does read the petitions that come to him. At least he will hear the other side. Up to this point the president has had to go on the STATICS from the CDC. Let us info him about the other side. As pain sufferers, DOCTORS, caregivers and more, do your part to help us change the minds of those who are not first hand witnesses to the pain we face and the loss of lives due to the lack of treatment. Thank you. If you don't want to sign at least read what the AMA house of delegates have said. Finally siding with us.
As chronic pain sufferers, we have had no voice even before the CDC guidelines. We have been ignored and abused. We have not been given the chance to tell our stories, the truth. Doctors are afraid to treat us and pharmacies turn us away. We have become the casualties of the war on drugs. We are asking that President Trump gives this petition direct attention and takes it seriously. We are good citizens of the United States of America and wish to live productive lives in this great nation. Update: 11/16/18 https://www.ama-assn.org/sites/default/files/media-browser/public/hod/i18-refcomm-b-annotated.pdf?fbclid=IwAR0fZa0zzrZmDHLNb-7iYh-f-vbqqN43P2VXsNGYbP6w5mdXY4hflbdAQWE Two and a half years after the release of the CDC’s opioid prescribing guideline, the American Medical Association has finally taken a stand against the “misapplication” and “inappropriate use” of the guideline by insurers, pharmacists, federal regulators and state governments. At its interim meeting in Maryland this week, the AMA House of Delegates adopted a series of resolutions that call for restraint in implementing the CDC guideline – particularly as it applies to the agency’s maximum recommend dose of 90mg MME (morphine equivalent units).
RESOLVED that our AMA affirms that some patients with acute or chronic pain can benefit from taking opioids at greater dosages than recommended by the CDC Guidelines for Prescribing Opioids for chronic pain and that such care may be medically necessary and appropriate.
RESOLVED that our AMA advocate against the misapplication of the CDC Guidelines for Prescribing Opioids by pharmacists, health insurers, pharmacy benefit managers, legislatures, and governmental and private regulatory bodies in ways that prevent or limit access to opioid analgesia.
RESOLVED that our AMA advocate that no entity should use MME thresholds as anything more than guidance, and physicians should not be subject to professional discipline, loss of board certification, loss of clinical privileges, criminal prosecution, civil liability, or other penalties or practice limitations solely for prescribing opioids at a quantitative level above the MME thresholds found in the CDC Guidelines for Prescribing Opioids. LET'S KEEP THIS GOING AND SEND IT TO THE PRESIDENT.
As chronic pain sufferers, we have had no voice even before the CDC guidelines. We have been ignored and abused. We have not been given the chance to tell our stories, the truth. Doctors are afraid to treat us and pharmacies turn us away. We have become the casualties of the war on drugs. We are asking that President Trump gives this petition direct attention and takes it seriously. We are good citizens of the United States of America and wish to live productive lives in this great nation. Update: 11/16/18 https://www.ama-assn.org/sites/default/files/media-browser/public/hod/i18-refcomm-b-annotated.pdf?fbclid=IwAR0fZa0zzrZmDHLNb-7iYh-f-vbqqN43P2VXsNGYbP6w5mdXY4hflbdAQWE Two and a half years after the release of the CDC’s opioid prescribing guideline, the American Medical Association has finally taken a stand against the “misapplication” and “inappropriate use” of the guideline by insurers, pharmacists, federal regulators and state governments. At its interim meeting in Maryland this week, the AMA House of Delegates adopted a series of resolutions that call for restraint in implementing the CDC guideline – particularly as it applies to the agency’s maximum recommend dose of 90mg MME (morphine equivalent units).
RESOLVED that our AMA affirms that some patients with acute or chronic pain can benefit from taking opioids at greater dosages than recommended by the CDC Guidelines for Prescribing Opioids for chronic pain and that such care may be medically necessary and appropriate.
RESOLVED that our AMA advocate against the misapplication of the CDC Guidelines for Prescribing Opioids by pharmacists, health insurers, pharmacy benefit managers, legislatures, and governmental and private regulatory bodies in ways that prevent or limit access to opioid analgesia.
RESOLVED that our AMA advocate that no entity should use MME thresholds as anything more than guidance, and physicians should not be subject to professional discipline, loss of board certification, loss of clinical privileges, criminal prosecution, civil liability, or other penalties or practice limitations solely for prescribing opioids at a quantitative level above the MME thresholds found in the CDC Guidelines for Prescribing Opioids. LET'S KEEP THIS GOING AND SEND IT TO THE PRESIDENT.